Adverse events associated with brolucizumab: a disproportionality analysis of the FDA adverse event reporting system (FAERS)

Conclusions Several unexpected ocular and systemic AE signals associated with brolucizumab were identified through data mining of the FAERS database.PMID:38404234 | DOI:10.1080/14740338.2024.2322712

Source: Expert Opinion on Drug Safety - February 26, 2024 Category: Drugs & Pharmacology Authors: Xiaomei Xiong Xiuwen Zhang Xiaoxia Li Taomin Huang Source Type: research